Initiatives underway to advance regenerative medicine program, identify cause of chronic illnesses, such as Lyme disease, Bartonellosis, rheumatoid arthritis, lupus, neuropsychiatric diseases and Crohn’s disease

MCLEAN, Va.-(BUSINESS WIRE)- With an emphasis on the discovery of infectious determinants of chronic diseases, a goal to reduce chronic disease worldwide and the dedication to make significant advances in regenerative medicine, the Thought Leadership & Innovation Foundation (TLI) is partnering with hospital systems and academic institutions and inviting donor support for the continuation of research.

Mayo Clinic has awarded a subcontract to the Thought Leadership & Innovation Foundation (TLI) to assist with the development and launch of a Limb Loss and Preservation Registry for the National Institute of Child Health and Human Development. This single award indefinite delivery/indefinite quantity (IDIQ) contract has a ceiling of $5 million over a five-year period. For the past three years, TLI has worked with the Mayo Clinic, the American Joint Replacement Registry (AJRR), and the American Orthotic & Prosthetic Association (AOPA) to advance rehabilitation of individuals having undergone limb loss and limb preservation surgeries.